Prognostic role of modified Glasgow Prognostic score in elderly non-small cell lung cancer patients treated with anti-PD-1 antibodies
Source : https://www.sciencedirect.com/science/article/abs/pii/S2212534522001447?via=ihub
Available online 29 November 2022 Author links open overlay panel Tomohiro Tanaka a Person b Envelope Show more This study aimed to investigate whether the immunosenescence-related score is a critical prognostic predictor of anti-programmed cell death protein 1 (PD-1) axis inhibitors in elderly patients with advanced non-small cell lung cancer (NSCLC).
Conclusions: High mGPS scores significantly impaired DCR, mPFS, and mOS in patients with advanced NSCLC treated with anti-PD-1 antibodies.
-
Albert DekkerDecember 15, 2022how different is this from old fashioned PS?